Vaccine approaches conferring cross-protection against influenza viruses
Introduction: Annual vaccination is one of the most efficient and cost-effective strategies to prevent and control influenza epidemics. Most of the currently available influenza vaccines are strong inducers of antibody responses against viral surface proteins, hemagglutinin (HA) and neuraminidase (N...
Main Authors: | Sai V Vemula, Ekramy E Sayedahmed, Suryaprakash Sambhara, Suresh K Mittal |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-11-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2017.1379396 |
Similar Items
-
Progress towards the Development of a Universal Influenza Vaccine
by: Wen-Chien Wang, et al.
Published: (2022-07-01) -
Preparedness for influenza vaccination during a pandemic in the World Health Organization Western Pacific Region
by: Leila Bell, et al.
Published: (2019-11-01) -
Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs– focus on the bigger picture
by: Nino Rcheulishvili, et al.
Published: (2022-10-01) -
A preclinical trial of the reassortant influenza virus vaccinе strain A/17/Quail/Hong Kong/97/84 (H9N2)
by: Yu. A. Desheva, et al.
Published: (2015-08-01) -
In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
by: Teddy John Wohlbold, et al.
Published: (2014-06-01)